A brief overview of academic detailing in Canada: Another role for pharmacists

Canadian Pharmacists Journal

Volumn 145, Issue 3, 2012, Pages 142-146

  Jin, Margaret ^a  

^a Hamilton Family Health Team   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARDIAC AGENT; DIURETIC AGENT; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ACADEMIC DETAILING; CANADA; CHRONIC PAIN; CONTINUING EDUCATION; DEPRESSION; DIABETES MELLITUS; DRUG COST; DRUG INFORMATION; DRUG UTILIZATION; EDUCATION PROGRAM; FUNDING; HEALTH CARE QUALITY; HEART FAILURE; HYPERTENSION; MEDICAL INFORMATION SYSTEM; PHARMACIST; PHYSICIAN; PRESCRIPTION; REVIEW; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

EID: 84861414902     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.3821/145.3.cpj142     Document Type: Review

References (48)

1. Canadian Institute for Health Information. Drug expenditure in Canada, 1985 to 2010. Ottawa (ON): Canadian Institute for Health Information; 2011. Available: http://secure.cihi.ca/cihiweb/products/drug_expenditure_2010_en.pdf (accessed July 14, 2011).
2. Campeau L. Top RxDrugs of 2010. Pharmacy Practice 2011;February/March:32-6.
3. Hanlon JT, Artz MB, Pieper CF, et al. Inappropriate medication use among frail elderly inpatients. Ann Pharmacother 2004;38:9-14.
4. Piecoro LT, Browning SR, Prince TS, et al. A database analysis of potentially inappropriate drug use in an elderly Medicaid population. Pharmacother 2000;20:221-8.
5. Lau E, Dolovich L. Drug-related problems in elderly general practice patients receiving pharmaceutical care. Int J Pharm Pract 2005;13:165-77.
6. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001;41:192-9.
7. Baker GR, Norton PG, Flintoft V, et al. The Canadian adverse events study: the incidence of adverse events among hospital patients in Canada. CMAJ 2004;170:1678-86.
8. Canadian Institute for Health Information. Hospital morbidity database 2000/01 Tabular reports. Ottawa (ON): Canadian Institute for Health Information; 2002. Available: http://secure.cihi.ca/cihiweb/products/HospitalMorbidityTabularReports2000-2001.pdf (accessed July 14, 2011).
9. Grimshaw JM, Shirran L, Thomas R, et al. Changing provider behavior: an overview of systematic reviews of interventions. Med Care 2001;39:I12-I45.
10. Knowledge Translation Program. Glossary of terms in knowledge translation and continuing education. 2006. KTClearinghouse. Available: http://ktclearinghouse.ca/knowledgebase/knowledgetoaction/action/interventions/strategies/academicdetailing (accessed April 5, 2012).
11. Coenen S, Van Royen P, Michiels B, Denekens J. Optimizing antibiotic prescribing for acute cough in general practice: a cluster-randomized controlled trial. J Antimicrob Chemother 2004;54:661-72.
12. Seager JM, Howell-Jones RS, Dunstan FD, et al. A randomised controlled trial of clinical outreach education to rationalise antibiotic prescribing for acute dental pain in the primary care setting. Br Dent J 2006;201:217-22
13. Solomon DH, Van Houten L, Glynn RJ, et al. Academic detailing to improve use of broad-spectrum antibiotics at an academic medical center. Arch Intern Med 2001;161:1897-902.
14. Berings D, Blondeel L, Habraken H. The effect of industry-independent drug information on the prescribing of benzodiazepines in general practice. Eur J Clin Pharmacol 1994;46:501-5.
15. de Burgh S, Mant A, Mattick RP, et al. A controlled trial of educational visiting to improve benzodiazepine prescribing in general practice. Aust J Public Health 1995;19:142-8.
16. Schmidt I, Claesson CB, Westerholm B, et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc 1998;46:77-82.
17. Newton-Syms FA, Dawson PH, Cooke J, et al. The influence of an academic representative on prescribing by general practitioners. Br J Clin Pharmacol 1992;33:69-73.
18. Pit SW, Byles JE, Henry DA, et al. A quality use of medicines program for general practitioners and older people: a clusterrandomised controlled trial. Med J Aust 2007;187:23-30.
19. Offman JJ, Segal R, Russell WL, et al. A randomized trial of an acid-peptic disease management program in a managed care environment. Am J Manag Care 2003;9:425-33.
20. Stafford RS, Bartholomew LK, Cushman WC, et al. Impact of the ALLHAT/JNC7 dissemination project on thiazide-type diuretic use. Arch Intern Med 2010;170:851-8.
21. Feder G, Griffiths C, Highton C, et al. Do clinical guidelines introduced with practice based education improve care of asthmatic and diabetic patients? A randomised controlled trial in general practices in east London. BMJ 1995;311:1473-8.
22. Solomon DH, Polinski JM, Stedman M, et al. Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 2007:362-7.
23. Young JM, D'Este C, Ward JE. Improving family physicians' use of evidence-based smoking cessation strategies: a cluster randomization trial. Prev Med 2002;35:572-83.
24. Kim CS, Kristopaitis RJ, Stone E, et al. Physician education and report cards: do they make the grade? Results from a randomized controlled trial. Am J Med 1999;107:556-60.
25. Walsh JM, Salazar R, Terdiman JP, et al. Promoting use of colorectal cancer screening tests. Can we change physician behaviour? J Gen Intern Med 2005;20:1097-101.
26. Sketris I, Langille E, Lummis H. Optimal prescribing and medication use in Canada: challenges and opportunities. Toronto (ON): Health Council of Canada; 2007. Available: http://publications.gc.ca/collections/collection_2007/hcc-ccs/H174-6-2007E.pdf (accessed July 14, 2011)
27. O'Brien MA, Rogers S, Jamtvedt G, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2007;(4):CD000409.
28. Freemantle N, Nazareth I, Eccles M, et al. A randomized controlled trial of the effect of educational outreach by community pharmacists on prescribing in UK general practice. Br J Gen Pract 2002;52:290-5.
29. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990;263:549-56.
30. Bacovsky R, Maclure M, Nyguyen A, et al. Canadian Academic Detailing Collaboration: evaluating processes and outcomes of academic detailing. Can Pharm J 2006;139:54-7.
31. Maclure M, Allen M, Bacovsky R, et al. Show me the evidence: best practices for using educational visits to promote evidence-based prescribing. Victoria (BC): Drug Policy Futures; 2006. Available: http://web.his.uvic.ca/dpf/index.php?Research_Themes:Academic_detailing (accessed July 14, 2011).
32. Maclure M, Nguyen A, et al. Measuring prescribing improvements in pragmatic trials of educational tools for general practitioners. Basic Clin Pharmacol Toxicol 2006;98:243-52.
33. Cordeiro J, Lauscher H, Olatunbosun T, et al. Physicianpharmacist electronic linkage for evidence informed prescribing: from project to provincial implementation in British Columbia. Poster Presentation. eHealth Conference 2011, Toronto, Ontario.
34. RxFi les. About us. Available: www.rxfiles.ca/rxfi les/modules/aboutus/AboutUs.aspx (accessed July 14, 2011).
35. Academic detailing service. Faculty of Medicine: continuing medical education. Dalhousie University. Available: http://cme.medicine.dal.ca/ADS.htm (accessed July 14, 2011).
36. Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach: a randomized controlled trial of academically based "detailing." N Engl J Med 1983;308:1457-63.
37. Avorn J, Soumerai SB, Everitt DE, et al. A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992;327:168-73.
38. Allen M, Ferrier S, O'Conner N, et al. Family physicians' perception of academic detailing: a quantitative and qualitative study. BMC Medical Education 2007;7:36.
39. Janssens I, De Meyere M, Habraken H, et al. Barriers to academic detailers: a qualitative study in general practice. Eur J Gen Pract 2005;11:59-63.
40. Soumerai SB, Avorn J. Principles of educational outreach ("academic detailing") to improve clinical decision making. JAMA 1990;263:549-56.
41. Davis DA, Thomson MA, Oxman AD, et al. Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995;274:700-5.
42. Freemantle N, Eastaugh J. Using effectiveness studies for prescribing research, part I. J Clin Pharm Ther 2002;27:383-9.
43. Mason J, Freemantle N, Nazareth I, et al. When is it costeffective to change the behavior of health professionals? JAMA 2001;286:2988-92.
44. Fretheim A, Aaserud M, Oxman AD. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice. PLoS Med 2006;3(6):e216.
45. Soumerai SB, Avorn J. Economic and policy analysis of university-based drug "detailing." Medical Care 1986;24:313-31.
46. Lemelin J, Hogg W, Baskerville N. Evidence to action: a tailored multifaceted approach to changing family physician practice patterns and improving preventive care. CMAJ 2001;164(6):757-63.
47. Steele MA, Bess DT, Franse VL, Graber SE. Cost effectiveness of two interventions for reducing outpatient prescribing costs. DICP 1989;23:497-500.
48. Coopers & Lybrand Consultants. Drug and therapeutics information service: update of the economic evaluation of the NSAID project. In: May FW, Rowett D, editors. DATIS progress report to the Department of Health and Family Services October to March 1995-96. Canberra: Australian Commonwealth Department of Health and Family Services;1996